| Literature DB >> 21504598 |
Kiriaque B F Barbosa1, Ana Carolina P Volp, Helen Hermana M Hermsdorff, Iñigo Navarro-Blasco, M Ángeles Zulet, J Alfredo Martínez, Josefina Bressan.
Abstract
BACKGROUND: Despite oxidized low density lipoprotein (ox-LDL) plays important roles in the pro-inflammatory and atherosclerotic processes, the relationships with metabolic and oxidative stress biomarkers have been only scarcely investigated in young adult people. Thus, the aim of this study was to assess plasma ox-LDL concentrations and the potential association with oxidative stress markers as well as with anthropometric and metabolic features in healthy young adults.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21504598 PMCID: PMC3110141 DOI: 10.1186/1476-511X-10-61
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Anthropometric, clinical, and biochemical data, categorized by the median (cutoff: 69.4 U/L) of ox-LDL concentrations (n = 160)
| Low ox-LDL | High ox-LDL | ||
|---|---|---|---|
| Women (%) | 60.8 | 52.6 | 0.305 |
| Age (y) | 23.1 ± 3.6 | 23.4 ± 3.4 | 0.145 |
| BMI (kg/m2) | 21.6 ± 2.8 | 22.4 ± 3.0 | |
| Waist circumference (cm) | 78.0 ± 8.7 | 78.3 ± 8.7 | 0.863 |
| Waist-to-hip ratio | 0.8 ± 0.1 | 0.8 ± 0.1 | 0.469 |
| Sum of 4 ST (mm) | 42.6 ± 16.8 | 45.0 ± 20.4 | 0.369 |
| Truncal fat (%) | 57.4 ± 7.1 | 59.3 ± 6.1 | 0.069 |
| Total body fat (%) | 23.8 ± 6.1 | 23.4 ± 7.0 | 0.735 |
| Body fat mass (kg) | 15.0 ± 5.2 | 14.7 ± 5.4 | 0.303 |
| Systolic blood pressure (mmHg) | 109 ± 9 | 110 ± 9 | 0.239 |
| Diastolic blood pressure (mmHg) | 74 ± 7 | 73 ± 7 | 0.257 |
| Glucose (mg/dL) | 90.8 ± 7.0 | 90.3 ± 6.3 | 0.394 |
| Insulin (μU/mL)** | 10.3 ± 5.0 | 10.2 ± 6.0 | 0.302 |
| HOMA-IR** | 2.3 ± 1.2 | 2.3 ± 1.3 | 0.245 |
| Total cholesterol (mg/dL) | 153.4 ± 27.8 | 166.5 ± 33.5 | |
| HDL-c (mg/dL) † | 47.3 ± 12.4 | 45.7 ± 10.4 | 0.342 |
| LDL-c (mg/dL) | 91.0 ± 26.6 | 100.2 ± 26.4 | |
| Triacylglycerol (mg/dL) | 96.1 ± 49.1 | 103.2 ± 38.5 | 0.059 |
| Total cholesterol-to-HDL-c ratio† | 3.3 ± 0.6 | 3.8 ± 0.9 | |
| Uric acid (mg/dL) | 3.4 ± 1.1 | 3.7 ± 1.1 | |
| GPx activity (nmol/[mL/min])‡ | 487.9 ± 231.3 | 659.1 ± 299.2 | |
| Selenium (ng/g of nail)§ | 396.2 ± 88.0 | 365.5 ± 76.7 | |
| Zinc (μg/g of nail)§ | 124.5 ± 57.7 | 132.3 ± 68.7 | 0.212 |
| Copper (μg/g of nail)§ | 7.4 ± 5.5 | 7.1 ± 7.1 | 0.247 |
Data are mean ± SD.
Ox-LDL, oxidized low density lipoprotein; BMI, body mass index; ST, skinfold thickness; HOMA-IR, homeostasis model assessment of insulin resistance; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; GPx, glutathione peroxidase.
*Student t test was performed for variables with normal distribution while remaining variables were analyzed by Mann-Whitney U test, as appropriate.
**n = 79 and n = 77, for low and high ox-LDL, respectively.
†n = 73 for high ox-LDL.
‡n = 44 and n = 56, for low and high ox-LDL, respectively.
§ n = 69 and n = 66, for low and high ox-LDL, respectively.
Lifestyle features of the participants, categorized by the median (cutoff: 69.4 U/L) of ox-LDL concentrations*
| Low ox-LDL | High ox-LDL | ||
|---|---|---|---|
| Vitamin supplement use (%) | 6.2 | 6.2 | 0.721 |
| Smokers (%)‡ | 9.6 | 13.4 | 0.105 |
| Smoking (cigarettes/d)‡ | 1.3 ± 4.9 | 1.6 ± 4.9 | 0.318 |
| Self-reported PA practice (%)‡ | 72.6 | 70.1 | 0.116 |
| MET (h/wk)‡ | 116 ± 105 | 135 ± 116 | 0.324 |
Ox-LDL, oxidized low density lipoprotein; PA, physical activity; MET, activity metabolic equivalent
*Data are mean ± SD or frequencies.
†P-value from χtest and Mann-Whitney U test for dichotomous and continuous variables, respectively.
‡n = 73 and n = 67, for low and high ox-LDL, respectively.
Multivariate linear regression analysis with ox-LDL concentrations (U/L) as a dependent variable (n = 160)*
| Predictors of ox-LDL | β coefficient (95% CI) | ||
|---|---|---|---|
| BMI (kg/m2) | 1.206 (-0.347 to 2.760) | 0.127 | 0.008 |
| Truncal fat (%) | 0.489 (-0.193 to 1.172) | 0.158 | 0.006 |
| Systolic blood pressure (mmHg) | 4.749 (-0.127 to 9.626) | 0.056 | 0.016 |
| Total cholesterol (mg/dL) | 0.228 (0.086 to 0.370) | ||
| LDL-c (mg/dL) | 0.216 (0.048 to 0.384) | ||
| Triacylglycerol (mg/dL) | 0.082 (-0.021 to 0.185) | 0.118 | 0.009 |
| Total cholesterol-to-HDL-c ratio** | 15.787 (10.776 to 20.798) | ||
| Uric acid (mg/dL) | 4.465 (0.342 to 8.588) | ||
| GPx activity (nmol/[mL/min])† | 0.029 (0.008 to 0.050) | ||
| Selenium (ng/g of nail)§ | -0.063 (-0.119 to -0.007) | ||
| Copper (μg/g of nail)§ | -0.573 (-1.322 to 0.176) | 0.132 | 0.009 |
Ox-LDL, oxidized low density lipoprotein; BMI, body mass index; ST, skinfold thickness; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol,
*Multivariate linear regressions, adjusted for gender, age, smoking, and physical activity.
**n = 153, † n = 100, §n = 135.
Figure 1Plasma ox-LDL concentrations (n = 100), according to tertiles of GPx activity. GPx activity into tertiles, 1st: <334, n = 33; 2nd: 334-611, n = 34; 3rd: ≥611 nmol/[mL/min], n = 33. Data are means and 95% CIs. P for trend, from linear regression models adjusted for gender, age, smoking status, physical activity, truncal fat, uric acid and total cholesterol concentrations.
Figure 2Plasma ox-LDL concentrations (n = 135), according to tertiles of nail selenium levels. Nail selenium levels into tertiles, 1st: <330, n = 45; 2nd: 330-430, n = 45; 3rd: ≥430 ng/g of nail, n = 45. Data are means and 95% CIs. P for trend, from linear regression models adjusted for gender, age, smoking status, physical activity, truncal fat, uric acid and total cholesterol concentrations.